Withdrawal: Expanding a key addiction construct

Nicotine and Tobacco Research

Volumn 17, Issue 12, 2015, Pages 1405-1415

  Piper, Megan E ^a  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COGNITION; ENVIRONMENTAL FACTOR; HUMAN; OUTCOME ASSESSMENT; PERSONAL EXPERIENCE; PRIORITY JOURNAL; REVIEW; SMOKING CESSATION; SOCIAL ASPECTS AND RELATED PHENOMENA; SYMPTOM; TOBACCO DEPENDENCE; WITHDRAWAL SYNDROME; WITHDRAWAL VARIABILITY; ADVERSE EFFECTS; BEHAVIOR, ADDICTIVE; MOTIVATION; PSYCHOLOGY; SMOKING; SUBSTANCE WITHDRAWAL SYNDROME;

NICOTINE;

BEHAVIOR, ADDICTIVE; HUMANS; MOTIVATION; NICOTINE; SMOKING; SUBSTANCE WITHDRAWAL SYNDROME;

EID: 84973091663     PISSN: 14622203     EISSN: 1469994X     Source Type: Journal    
DOI: 10.1093/ntr/ntv048     Document Type: Review

References (126)

1. Edwards G, Gross MM. Alcohol dependence: provisional description of a clinical syndrome. BMJ. 1976;1(6017):1058-1061.
2. Siegel S. Classical conditioning, drug tolerance, and drug dependence. In: Smart RG, Glaser FB, Israel Y, Kalant R, Popham E, Schmidt W, eds. Research Advances in Alcohol and Drug Problems. 7th ed. New York, NY: Plenum; 1983.
3. Solomon RL, Corbit JD. An opponent-process theory of motivation. I. Temporal dynamics of affect. Psychol Rev. 1974;81(2):119-145. doi:10.1037/h0036128.
4. Wikler A. Opioid Dependence. New York, NY: Plenum; 1980.
5. U.S. Department of Health and Human Services. The Health Consequences of Smoking: Nicotine Addiction. Atlanta, GA: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health; 1988.
6. American Psychiatric Association. Diagnostic and Statistical Manual. Vol V. Washington, DC: American Psychiatric Association; 2013.
7. Shiftman S. The tobacco withdrawal syndrome. In: Krasnegor NA, ed. Cigarette Smoking as a Dependence Process. Washington, DC: National Institute on Drug Abuse; 1979:158-184.
8. Welsch SK, Smith SS, Wetter DW, Jorenby DE, Fiore MC, Baker TB. Development and validation of the Wisconsin Smoking Withdrawal Scale. Exp Clin Psychopharmacol. 1999;7(4):354-361. doi:10.1037/1064-1297.7.4.354.
9. Hughes JR, Hatsukami D. Signs and symptoms of tobacco withdrawal. Arch Gen Psychiatry. 1986;43(3):289-294.
10. Dawkins L, Powell JH, Pickering A, Powell J, West R. Patterns of change in withdrawal symptoms, desire to smoke, reward motivation and response inhibition across 3 months of smoking abstinence. Addiction. 2009;104(5):850-858. doi:10.1111/j.1360-0443.2009.02522.x.
11. Hughes JR. Effects of abstinence from tobacco: etiology, animal models, epidemiology, and significance: a subjective review. Nicotine Tob Res. 2007;9(3):329-339. doi:10.1080/14622200701188927.
12. Hughes JR. Effects of abstinence from tobacco: valid symptoms and time course. Nicotine Tob Res. 2007;9(3):315-327. doi:10.1080/14 622200701188919.
13. Leventhal AM, Waters AJ, Moolchan ET, Heishman SJ, Pickworth WB. A quantitative analysis of subjective, cognitive, and physiological manifestations of the acute tobacco abstinence syndrome. Addict Behav. 2010;35(12):1120-1130. doi:10.1016/j.addbeh.2010.08.007.
14. West R, Ussher M, Evans M, Rashid M. Assessing DSM-IV nicotine withdrawal symptoms: a comparison and evaluation of five different scales. Psychopharmacology (Berl). 2006;184(3-4):619-627.
15. Hughes JR. Measurement of the effects of abstinence from tobacco: a qualitative review. Psychol Addict Behav. 2007;21(2):127-137. doi:10.1037/0893-164X.21.2.127.
16. Payne TJ, Smith PO, McCracken LM, McSherry WC, Antony MM. Assessing nicotine dependence: a comparison of the Fagerstrom Tolerance Questionnaire (FTQ) with the Fagerstrom Test for Nicotine Dependence (FTND) in a clinical sample. Addict Behav. 1994;19(3):307-317. doi:10.1016/0306-4603(94)90032-9.
17. Piper ME, McCarthy DE, Baker TB. Assessing tobacco dependence: a guide to measure evaluation and selection. Nicotine Tob Res. 2006;8(3):339-351. doi:10.1080/14622200600672765.
18. Rios-Bedoya CF, Snedecor SM, Pomerleau CS, Pomerleau OF. Association of withdrawal features with nicotine dependence as measured by the Fagerstrom Test for Nicotine Dependence (FTND). Addict Behav. 2008;33(8):1086-1089. doi:10.1016/j.addbeh.2008.04.005.
19. Shiffman S, Waters A, Hickcox M. The nicotine dependence syndrome scale: a multidimensional measure of nicotine dependence. Nicotine Tob Res. 2004;6(2):327-348. doi:10.1080/1462220042000202481.
20. Shiffman S, Patten C, Gwaltney C, et al. Natural history of nicotine withdrawal. Addiction. 2006;101(12):1822-1832. doi:10.1111/j.1360-0443.2006.01635.x.
21. Shiffman S, West R, Gilbert D; SRNT Work Group on the Assessment of Craving Withdrawal in Clinical Trials. Recommendation for the assessment of tobacco craving and withdrawal in smoking cessation trials. Nicotine Tob Res. 2004;6(4):599-614. doi:10.1080/14622200410001734067.
22. Herd N, Borland R. The natural history of quitting smoking: findings from the International Tobacco Control (ITC) Four Country Survey. Addiction. 2009;104(12):2075-2087. doi:10.1111/j.1360-0443.2009.02731.x.
23. Hughes JR. Craving among long-abstinent smokers: an Internet survey. Nicotine Tob Res. 2010;12(4):459-462. doi:10.1093/ntr/ntq009.
24. Baker TB, Piper ME, Schlam TR, et al. Are tobacco dependence and withdrawal related amongst heavy smokers? Relevance to conceptualizations of dependence. J Abnorm Psychol. 2012;121(4):909-921. doi:10.1037/a0027889.
25. Wray JM, Gass JC, Tiffany ST. A systematic review of the relationships between craving and smoking cessation. Nicotine Tob Res. 2013;15(7):1167-1182. doi:10.1093/ntr/nts268.
26. Cappelleri JC, Bushmakin AG, Baker CL, Merikle E, Olufade AO, Gilbert DG. Revealing the multidimensional framework of the Minnesota nicotine withdrawal scale. Curr Med Res Opin. 2005;21(5):749-760.
27. Toll BA, O'Malley SS, McKee SA, Salovey P, Krishnan-Sarin S. Confirmatory factor analysis of the Minnesota Nicotine Withdrawal Scale. Psychol Addict Behav. 2007;21(2):216-225.
28. Dijkstra BA, Krabbe PF, De Jong CA, van der Staak CP. Prediction of withdrawal symptoms during opioid detoxification. J Opioid Manag. 2008;4(5):311-319.
29. Hesse M, Thylstrup B. Time-course of the DSM-5 cannabis withdrawal symptoms in poly-substance abusers. BMC Psychiatry. 2013;13:258-269. doi:10.1186/1471-244X-13-258.
30. Piasecki TM, Niaura R, Shadel WG, et al. Smoking withdrawal dynamics in unaided quitters. J Abnorm Psychol. 2000;109(1):74-86. doi:10.1037/0021-843X.109.1.74.
31. Piper ME, Schlam TR, Cook JW, et al. Tobacco withdrawal components and their relations with cessation success. Psychopharmacology (Berl). 2011;216(4):569-578. doi:10.1007/s00213-011-2250-3.
32. McCarthy DE, Piasecki TM, Fiore MC, Baker TB. Life before and after quitting smoking: an electronic diary study. J Abnorm Psychol. 2006;115(3):454-466.
33. Hendricks PS, Ditre JW, Drobes DJ, Brandon TH. The early time course of smoking withdrawal effects. Psychopharmacology (Berl). 2006;187(3):385-396.
34. Davidson RJ, Jackson DC, Kalin NH. Emotion, plasticity, context, and regulation: perspectives from affective neuroscience. Psychol Bull. 2000;126(6):890-909.
35. Piper ME, Smith SS, Schlam TR, et al. Psychiatric disorders in smokers seeking treatment for tobacco dependence: relations with tobacco dependence and cessation. J Consult Clin Psychol. 2010;78(1):13-23. doi:10.1037/a0018065.
36. Bradford DE, Magruder KP, Korhumel RA, Curtin JJ. Using the threat probability task to assess anxiety and fear during uncertain and certain threat. J Vis Exp. 2014(91):51905. doi:10.3791/51905.
37. Bradford DE, Shapiro BL, Curtin JJ. How bad could it be? Alcohol dampens stress responses to threat of uncertain intensity. Psychol Sci. 2013;24(12):2541-2549. doi:10.3791/51905.
38. Hefner KR, Moberg CA, Hachiya LY, Curtin JJ. Alcohol stress response dampening during imminent versus distal, uncertain threat. J Abnorm Psychol. 2013;122(3):756-769. doi:10.1037/a0033407.
39. Rubinstein ML, Benowitz NL, Auerback GM, Moscicki AB. Rate of nicotine metabolism and withdrawal symptoms in adolescent light smokers. Pediatrics. 2008;122(3):e643-e647. doi:10.1542/peds.2007-3679.
40. Kubota T, Nakajima-Taniguchi C, Fukuda T, et al. CYP2A6 polymorphisms are associated with nicotine dependence and influence withdrawal symptoms in smoking cessation. Pharmacogenomics J. 2006;6(2):115-119.
41. Vasilenko SA, Piper ME, Lanza ST, Liu X, Yang J, Li R. Time-varying processes involved in smoking lapse in a randomized trial of smoking cessation therapies. Nicotine Tob Res. 2014;16(suppl 2):S135-143. doi:10.1093/ntr/ntt185.
42. Wikler A. Dynamics of drug dependence. Implications of a conditioning theory for research and treatment. Arch Gen Psychiatry. 1973;28(5):611-616.
43. Wang Z, Faith M, Patterson F, et al. Neural substrates of abstinence-induced cigarette cravings in chronic smokers. J Neurosci. 2007;27(51):14035-14040.
44. Curtin JJ, McCarthy DE, Piper ME, Baker TB. Implicit and explicit drug motivational processes: a model of boundary conditions. In: Weirs RW, Stacy AW, eds. Handbook of Implicit Cognition and Addiction. Thousand Oaks, CA: Sage; 2006:233-250.
45. Stoker AK, Markou A. Unraveling the neurobiology of nicotine dependence using genetically engineered mice. Curr Opin Neurobiol. 2013;23(4):493-499. doi:10.1016/j.conb.2013.02.013.
46. Lazary J, Dome P, Csala I, et al. Massive withdrawal symptoms and affective vulnerability are associated with variants of the CHRNA4 gene in a subgroup of smokers. PLoS One. 2014;9(1):e87141. doi:10.1371/journal. pone.0087141.
47. Jackson KJ, Sanjakdar SS, Chen X, Damaj MI. Nicotine reward and affective nicotine withdrawal signs are attenuated in calcium/calmodulin-dependent protein kinase IV knockout mice. PLoS One. 2012;7(11):e51154. doi:10.1371/journal.pone.0051154.
48. Xu X, Clark US, David SP, et al. Effects of nicotine deprivation and replacement on BOLD-fMRI response to smoking cues as a function of DRD4 VNTR genotype. Nicotine Tob Res. 2014;16(7):939-947. doi:10.1093/ntr/ntu010.
49. Weiss RB, Baker TB, Cannon DS, et al. A candidate gene approach identifies the CHRNA5-A3-B4 region as a risk factor for age-dependent nicotine addiction. PLoS Genet. 2008;4(7):e1000125. doi:10.1371/journal.pgen.
50. Berrettini W, Yuan X, Tozzi F, et al. Alpha-5/alpha-3 nicotinic receptor subunit alleles increase risk for heavy smoking. Mol Psychiatry. 2008;13(4):368-373. doi:10.1038/sj.mp.4002154.
51. Saccone SF, Hinrichs AL, Saccone NL, et al. Cholinergic nicotinic receptor genes implicated in a nicotine dependence association study targeting 348 candidate genes with 3713 SNPs. Hum Mol Genet. 2007;16(1):36-49.
52. Thorgeirsson TE, Geller F, Sulem P, et al. A variant associated with nicotine dependence, lung cancer and peripheral arterial disease. Nature. 2008;452(7187):638-642. doi:10.1038/nature06846.
53. Kolokotroni KZ, Rodgers RJ, Harrison AA. Trait differences in response to chronic nicotine and nicotine withdrawal in rats. Psychopharmacology (Berl). 2014;231(3):567-580. doi:10.1007/s00213-013-3270-y.
54. Kayir H, Semenova S, Markou A. Baseline impulsive choice predicts the effects of nicotine and nicotine withdrawal on impulsivity in rats. Prog Neuropsychopharmacol Biol Psychiatry. 2014;48:6-13. doi:10.1016/j. pnpbp.2013.09.007.
55. Torres OV, Gentil LG, Natividad LA, Carcoba LM, O'Dell LE. Behavioral, biochemical, and molecular indices of stress are enhanced in female versus male rats experiencing nicotine withdrawal. Front Psychiatry. 2013;4:38. doi:10.3389/fpsyt.2013.00038.
56. Smith PH, Homish GG, Giovino GA, Kozlowski LT. Cigarette smoking and mental illness: a study of nicotine withdrawal. Am J Public Health. 2014;104(2):e127-e133. doi:10.2105/AJPH.2013.301502.
57. Marshall EC, Johnson K, Bergman J, Gibson LE, Zvolensky MJ. Anxiety sensitivity and panic reactivity to bodily sensations: relation to quitday (acute) nicotine withdrawal symptom severity among daily smokers making a self-guided quit attempt. Exp Clin Psychopharmacol. 2009;17(5):356-364. doi:10.1037/a0016883.
58. Piper ME, Cook JW, Schlam TR, Jorenby DE, Baker TB. Anxiety diagnoses in smokers seeking cessation treatment: relations with tobacco dependence, withdrawal, outcome and response to treatment. Addiction. 2011;106(2):418-427. doi:10.1111/j.1360-0443.2010.03173.x.
59. Leventhal AM, Waters AJ, Boyd S, et al. Associations between Cloninger's temperament dimensions and acute tobacco withdrawal. Addict Behav. 2007;32(12):2976-2989. doi:10.1016/j.addbeh.2007.06.014.
60. Leventhal AM, Waters AJ, Boyd S, Moolchan ET, Lerman C, Pickworth WB. Gender differences in acute tobacco withdrawal: effects on subjective, cognitive, and physiological measures. Exp Clin Psychopharmacol. 2007;15(1):21-36. doi:10.1037/1064-1297.15.1.21.
61. Sirota AD, Rohsenow DJ, Mackinnon SV, et al. Intolerance for Smoking Abstinence Questionnaire: psychometric properties and relationship to tobacco dependence and abstinence. Addict Behav. 2010;35(7):686-693. doi:10.1016/j.addbeh.2010.02.014.
62. Hendricks PS, Leventhal AM. Abstinence-related expectancies predict smoking withdrawal effects: implications for possible causal mechanisms. Psychopharmacology (Berl). 2013;230(3):363-373. doi:10.1007/s00213-013-3169-7.
63. Brown RA, Lejuez CW, Strong DR, et al. A prospective examination of distress tolerance and early smoking lapse in adult self-quitters. Nicotine Tob Res. 2009;11(5):493-502. doi:10.1093/ntr/ntp041.
64. Carter BL, Tiffany ST. Cue-reactivity and the future of addiction research. Addiction. 1999;94(3):349-351.
65. Rose JE. Nicotine and nonnicotine factors in cigarette addiction. Psychopharmacology (Berl). 2006;184(3-4):274-285.
66. Henningfield JE, Goldberg SR. Control of behavior by intravenous nicotine injections in human subjects. Pharmacol Biochem Behav. 1983;19(6):1021-1026.
67. Cofta-Woerpel L, McClure JB, Li Y, Urbauer D, Cinciripini PM, Wetter DW. Early cessation success or failure among women attempting to quit smoking: trajectories and volatility of urge and negative mood during the first postcessation week. J Abnorm Psychol. 2011;120(3):596-606. doi:10.1037/a0023755.
68. Waters AJ, Shiffman S, Sayette MA, Paty JA, Gwaltney CJ, Balabanis MH. Cue-provoked craving and nicotine replacement therapy in smoking cessation. J Consult Clin Psychol. 2004;72(6):1136-1143. doi:10.1037/0022-006X.72.6.1136.
69. Teneggi V, Tiffany ST, Squassante L, Milleri S, Ziviani L, Bye A. Smokers deprived of cigarettes for 72 h: effect of nicotine patches on craving and withdrawal. Psychopharmacology (Berl). 2002;164(2):177-187. doi:10.1007/s00213-002-1176-1.
70. Robinson TE, Berridge KC. The neural basis of drug craving: an incentivesensitization theory of addiction. Brain Res Rev. 1993;18(3):247-291.
71. Hughes JR, Lesmes GR, Hatsukami DK, et al. Are higher doses of nicotine replacement more effective for smoking cessation? Nicotine Tob Res. 1999;1(2):169-174.
72. Hurt RD, Sachs DP, Glover ED, et al. A comparison of sustainedrelease bupropion and placebo for smoking cessation. N Engl J Med. 1997;337(17):1195-1202.
73. Jorenby DE, Leischow SJ, Nides MA, et al. A controlled trial of sustainedrelease bupropion, a nicotine patch, or both for smoking cessation. N Engl J Med. 1999;340(9):685-691.
74. Ferguson SG, Shiffman S. The relevance and treatment of cue-induced cravings in tobacco dependence. J Subst Abuse Treat. 2009;36(3):235-243. doi:10.1016/j.jsat.2008.06.005.
75. Ravva P, Gastonguay MR, Faessel HM, Lee TC, Niaura R. Pharmacokinetic-pharmacodynamic modeling of the effect of varenicline on nicotine craving in adult smokers. Nicotine Tob Res. 2015;17(1):106-113. doi:10.1093/ntr/ntu154.
76. Addicott MA, Froeliger B, Kozink RV, et al. Nicotine and non-nicotine smoking factors differentially modulate craving, withdrawal and cerebral blood flow as measured with arterial spin labeling. Neuropsychopharmacology. 2014;39(12):2750-2759. doi:10.1038/npp.2014.108.
77. Shiffman S, Dunbar M, Kirchner T, et al. Smoker reactivity to cues: effects on craving and on smoking behavior. J Abnorm Psychol. 2013;122(1):264-280. doi:10.1037/a0028339.
78. Engelmann JM, Versace F, Robinson JD, et al. Neural substrates of smoking cue reactivity: a meta-analysis of fMRI studies. Neuroimage. 2012;60(1):252-262. doi:10.1016/j.neuroimage.2011.12.024.
79. Lam CY, Businelle MS, Aigner CJ, et al. Individual and combined effects of multiple high-risk triggers on postcessation smoking urge and lapse. Nicotine Tob Res. 2014;16(5):569-575. doi:10.1093/ntr/ntt190.
80. Piper ME, Bolt DM, Kim SY, et al. Refining the tobacco dependence phenotype using the Wisconsin Inventory of Smoking Dependence Motives. J Abnorm Psychol. 2008;117(4):747-761. doi:10.1037/a0013298.
81. McClernon FJ, Kozink RV, Rose JE. Individual differences in nicotine dependence, withdrawal symptoms, and sex predict transient fMRI-BOLD responses to smoking cues. Neuropsychopharmacology. 2008;33(9):2148-2157. doi:10.1038/sj.npp.1301618.
82. Michalowski A, Erblich J. Reward dependence moderates smoking-cueand stress-induced cigarette cravings. Addict Behav. 2014;39(12):1879-1883. doi:10.1016/j.addbeh.2014.07.032.
83. Doran N. Sex differences in smoking cue reactivity: craving, negative affect, and preference for immediate smoking. Am J Addict. 2014;23(3):211-217. doi:10.1111/j.1521-0391.2014.12094.x.
84. Fagerström K. Determinants of tobacco use and renaming the FTND to the Fagerstrom Test for Cigarette Dependence. Nicotine Tob Res. 2012;14(1):75-78. doi:10.1093/ntr/ntr137.
85. Baker TB, Japuntich SJ, Hogle JM, McCarthy DE, Curtin JJ. Pharmocologic and behavioral withdrawal from addictive drugs. Curr Dir Psychol Sci. 2006;15(5):232-236. doi:10.1111/j.1467-8721.2006.00442.x.
86. Perkins KA, Ciccocioppo M, Conklin CA, Milanak ME, Grottenthaler A, Sayette MA. Mood influences on acute smoking responses are independent of nicotine intake and dose expectancy. J Abnorm Psychol. 2008;117(1):79-93. doi:10.1037/0021-843X.117.1.79.
87. Cosgrove KP, Batis J, Bois F, et al. beta2-Nicotinic acetylcholine receptor availability during acute and prolonged abstinence from tobacco smoking. Arch Gen Psychiatry. 2009;66(6):666-676. doi:10.1001/archgenpsychiatry.2009.41.
88. Butschky MF, Bailey D, Henningfield JE, Pickworth WB. Smoking without nicotine delivery decreases withdrawal in 12-hour abstinent smokers. Pharmacol Biochem Behav. 1995;50(1):91-96.
89. Gross J, Lee J, Stitzer ML. Nicotine-containing versus de-nicotinized cigarettes: effects on craving and withdrawal. Pharmacol Biochem Behav. 1997;57(1-2):159-165.
90. Donny EC, Houtsmuller E, Stitzer ML. Smoking in the absence of nicotine: behavioral, subjective and physiological effects over 11 days. Addiction. 2007;102(2):324-334. doi:10.1111/j.1360-0443.2006.01670.x.
91. Buchhalter AR, Acosta MC, Evans SE, Breland AB, Eissenberg T. Tobacco abstinence symptom suppression: the role played by the smoking-related stimuli that are delivered by denicotinized cigarettes. Addiction. 2005;100(4):550-559. doi:10.1111/j.1360-0443.2005.01030.x.
92. Rose JE, Behm FM. Extinguishing the rewarding value of smoke cues: pharmacological and behavioral treatments. Nicotine Tob Res. 2004;6(3):523-532. doi:10.1080/14622200410001696501.
93. Domino EF, Ni L, Domino JS, et al. Denicotinized versus average nicotine tobacco cigarette smoking differentially releases striatal dopamine. Nicotine Tob Res. 2013;15(1):11-21. doi:10.1093/ntr/nts029.
94. Juliano LM, Brandon TH. Effects of nicotine dose, instructional set, and outcome expectancies on the subjective effects of smoking in the presence of a stressor. J Abnorm Psychol. 2002;111(1):88-97.
95. Pickworth WB, Fant RV, Nelson RA, Rohrer MS, Henningfield JE. Pharmacodynamic effects of new de-nicotinized cigarettes. Nicotine Tob Res. 1999;1(4):357-364.
96. Tidey JW, Rohsenow DJ, Kaplan GB, Swift RM, Ahnallen CG. Separate and combined effects of very low nicotine cigarettes and nicotine replacement in smokers with schizophrenia and controls. Nicotine Tob Res. 2013;15(1):121-129. doi:10.1093/ntr/nts098.
97. Balfour DJ. The neurobiology of tobacco dependence: a preclinical perspective on the role of the dopamine projections to the nucleus accumbens [corrected]. Nicotine Tob Res. 2004;6(6):899-912.
98. Kenny PJ, Markou A. Nicotine self-administration acutely activates brain reward systems and induces a long-lasting increase in reward sensitivity. Neuropsychopharmacology. 2006;31(6):1203-1211.
99. Kenny PJ, Markou A. Conditioned nicotine withdrawal profoundly decreases the activity of brain reward systems. J Neurosci. 2005;25(26):6208-6212.
100. Pergadia ML, Der-Avakian A, D'Souza MS, et al. Association between nicotine withdrawal and reward responsiveness in humans and rats. JAMA Psychiatry. 2014;71(11):1238-1245. doi:10.1001/jamapsychiatry.2014.1016.
101. Cook JW, Piper ME, Leventhal AM, Schlam TR, Fiore MC, Baker TB. Anhedonia as a component of the tobacco withdrawal syndrome. J Abnorm Psychol. 2015;124(1):215-225.
102. Leventhal AM, Piper ME, Japuntich SJ, Baker TB, Cook JW. Anhedonia, depressed mood, and smoking cessation outcome. J Consult Clin Psychol. 2014;82(1):122-129. doi:10.1037/a0035046.
103. Versace F, Lam CY, Engelmann JM, et al. Beyond cue reactivity: blunted brain responses to pleasant stimuli predict longterm smoking abstinence. Addict Biol. 2012;17(6):991-1000. doi:10.1111/j.1369-1600.2011.00372.x.
104. MacPherson L, Tull MT, Matusiewicz AK, et al. Randomized controlled trial of behavioral activation smoking cessation treatment for smokers with elevated depressive symptoms. J Consult Clin Psychol. 2010;78(1):55-61. doi:10.1037/a0017939.
105. Pratt LA, Brody DJ. Depression and smoking in the U.S. household population aged 20 and over, 2005-2008. NCHS Data Brief. 2010;(34):1-8.
106. McClave AK, McKnight-Eily LR, Davis SP, Dube SR. Smoking characteristics of adults with selected lifetime mental illnesses: results from the 2007 National Health Interview Survey. Am J Public Health. 2010;100(12):2464-2472. doi:10.2105/AJPH.2009.188136.
107. Spring B, Pingitore R, McChargue DE. Reward value of cigarette smoking for comparably heavy smoking schizophrenic, depressed, and nonpatient smokers. Am J Psychiatry. 2003;160(2):316-322.
108. Ussher M, West R, Steptoe A, McEwen A. Increase in common cold symptoms and mouth ulcers following smoking cessation. Tob Control. 2003;12(1):86-88.
109. Hajek P, Gillison F, McRobbie H. Stopping smoking can cause constipation. Addiction. 2003;98(11):1563-1567.
110. Hughes JR, Dash M, Callas P. Is impulsivity a symptom of initial tobacco withdrawal? a meta-analysis and qualitative systematic review [published online ahead of print 2014]. Nicotine Tob Res. 2014. doi:10.1093/ntr/ntu220.
111. Etter JF, Ussher M, Hughes JR. A test of proposed new tobacco withdrawal symptoms. Addiction. 2013;108(1):50-59. doi:10.1111/j.1360-0443.2012.03981.x.
112. Piasecki TM, Fiore MC, McCarthy DE, Baker TB. Have we lost our way? The need for dynamic formulations of smoking relapse proneness. Addiction. 2002;97(9):1093-1108.
113. Muraven M, Tice DM, Baumeister RF. Self-control as limited resource: regulatory depletion patterns. J Pers Soc Psychol. 1998;74(3):774-789.
114. Hagger MS, Wood C, Stiff C, Chatzisarantis NL. Ego depletion and the strength model of self-control: a meta-analysis. Psychol Bull. 2010;136(4):495-525. doi:10.1037/a0019486.
115. Vohs KD, Heatherton TF. Self-regulatory failure: a resource-depletion approach. Psychol Sci. 2000;11(3):249-254.
116. Inzlicht M, Schmeichel B. What is ego depletion? Toward a mechanistic revision of the resource model of self-control. Perspectives Psychol Sci. 2012;7(5):450-463. doi:10.1177/1745691612454134.
117. Liu X, Li R, Lanza ST, Vasilenko SA, Piper M. Understanding the role of cessation fatigue in the smoking cessation process. Drug Alcohol Depend. 2013;133(2):548-555. doi:10.1016/j. drugalcdep.2013.07.025.
118. Bolt DM, Piper ME, Theobald WE, Baker TB. Why two smoking cessation agents work better than one: role of craving suppression. J Consult Clin Psychol. 2012;80(1):54-65. doi:10.1037/a0026366.
119. Shiyko MP, Lanza ST, Tan X, Li R, Shiffman S. Using the time-varying effect model (TVEM) to examine dynamic associations between negative affect and self confidence on smoking urges: differences between successful quitters and relapsers. Prev Sci. 2012;13(3):288-299. doi:10.1007/s11121-011-0264-z.
120. Panksepp J, Knutson B, Burgdorf J. The role of brain emotional systems in addictions: a neuro-evolutionary perspective and new 'self-report' animal model. Addiction. 2002;97(4):459-469.
121. Baker TB, Piper ME, McCarthy DE, Majeskie MR, Fiore MC. Addiction motivation reformulated: an affective processing model of negative reinforcement. Psychol Rev. 2004;111(1):33-51.
122. Germeroth LJ, Wray JM, Tiffany ST. Response time to craving-item ratings as an implicit measure of craving-related processes [published online ahead of print 2014]. Clin Psychol Sci. 2014. doi:10.1177/2167702614542847
123. Javitz HS, Brigham J, Lessov-Schlaggar CN, Krasnow RE, Swan GE. Association of tobacco dependence and quit attempt duration with Raschmodeled withdrawal sensitivity using retrospective measures. Addiction. 2009;104(6):1027-1035. doi:10.1111/j.1360-0443.2009.02540.x.
124. Piasecki TM, Jorenby DE, Smith SS, Fiore MC, Baker TB. Smoking withdrawal dynamics: I. Abstinence distress in lapsers and abstainers. J Abnorm Psychol. 2003;112(1):3-13. doi:10.1037/0021-843X.112.1.3.
125. Zhou X, Nonnemaker J, Sherrill B, Gilsenan AW, Coste F, West R. Attempts to quit smoking and relapse: factors associated with success or failure from the ATTEMPT cohort study. Addict Behav. 2009;34(4):365-373. doi:10.1016/j.addbeh.2008.11.013.
126. Ferguson SG, Shiffman S, Gwaltney CJ. Does reducing withdrawal severity mediate nicotine patch efficacy? A randomized clinical trial. J Consult Clin Psychol. 2006;74(6):1153-1161. doi:10.1037/0022-006X.74.6.1153.